Benitec Biopharma Ltd ADR (BNTC) SEC filings
Benitec Biopharma Ltd ADR (BNTC) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported BNTC revenue for 2025-09-30 was $0. Net income was -$9.0M. BNTC currently screens at market cap $388.7M. The BNTC filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Benitec Biopharma Ltd ADR said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
0
8-K
0
Form 4
No cached SEC filings for BNTC yet. When an 8-K lands, this page will show the exhibit headline and numbers.
Open EDGAREDGAR is the official archive. Browse all BNTC filings.
Frequently asked questions
What did BNTC just say?
BNTC cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are BNTC SEC filings?
0 cached filings are on this page. EDGAR remains the official archive.
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.